Aprogen Biologics Inc. (KRX:003060)
South Korea · Delayed Price · Currency is KRW 659.00
+19.00 (2.97%)
At close: Jul 17, 2025, 3:30 PM KST
Aprogen Biologics Market Cap
Aprogen Biologics has a market cap or net worth of 130.20 billion as of July 18, 2025. Its market cap has increased by 90.03% in one year.
Market Cap
130.20B
Enterprise Value
245.33B
Revenue
68.62B
Ranking
n/a
PE Ratio
n/a
Stock Price
659.00
Market Cap Chart
Since January 5, 1996, Aprogen Biologics's market cap has increased from 3.18B to 130.20B, an increase of 3,993.62%. That is a compound annual growth rate of 13.38%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 76.16T |
| Celltrion | 39.82T |
| ALTEOGEN | 26.19T |
| Yuhan | 9,866.54B |
| SK Biopharmaceuticals | 8,066.26B |
| HLB Co., Ltd. | 7,083.28B |
| Peptron | 6,861.07B |
| PharmaResearch | 5,890.93B |